Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 17 |
NetGPI | no | yes: 0, no: 17 |
Related structures:
AlphaFold database: A4IDN3
Term | Name | Level | Count |
---|---|---|---|
GO:0006468 | protein phosphorylation | 5 | 18 |
GO:0006793 | phosphorus metabolic process | 3 | 18 |
GO:0006796 | phosphate-containing compound metabolic process | 4 | 18 |
GO:0006807 | nitrogen compound metabolic process | 2 | 18 |
GO:0008152 | metabolic process | 1 | 18 |
GO:0009987 | cellular process | 1 | 18 |
GO:0016310 | phosphorylation | 5 | 18 |
GO:0019538 | protein metabolic process | 3 | 18 |
GO:0036211 | protein modification process | 4 | 18 |
GO:0043170 | macromolecule metabolic process | 3 | 18 |
GO:0043412 | macromolecule modification | 4 | 18 |
GO:0044237 | cellular metabolic process | 2 | 18 |
GO:0044238 | primary metabolic process | 2 | 18 |
GO:0071704 | organic substance metabolic process | 2 | 18 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 18 |
Term | Name | Level | Count |
---|---|---|---|
GO:0000166 | nucleotide binding | 3 | 18 |
GO:0003676 | nucleic acid binding | 3 | 6 |
GO:0003746 | translation elongation factor activity | 4 | 6 |
GO:0003824 | catalytic activity | 1 | 18 |
GO:0004672 | protein kinase activity | 3 | 18 |
GO:0004674 | protein serine/threonine kinase activity | 4 | 18 |
GO:0005488 | binding | 1 | 18 |
GO:0005524 | ATP binding | 5 | 18 |
GO:0008135 | translation factor activity, RNA binding | 3 | 6 |
GO:0016301 | kinase activity | 4 | 18 |
GO:0016740 | transferase activity | 2 | 18 |
GO:0016772 | transferase activity, transferring phosphorus-containing groups | 3 | 18 |
GO:0016773 | phosphotransferase activity, alcohol group as acceptor | 4 | 18 |
GO:0017076 | purine nucleotide binding | 4 | 18 |
GO:0030554 | adenyl nucleotide binding | 5 | 18 |
GO:0032553 | ribonucleotide binding | 3 | 18 |
GO:0032555 | purine ribonucleotide binding | 4 | 18 |
GO:0032559 | adenyl ribonucleotide binding | 5 | 18 |
GO:0035639 | purine ribonucleoside triphosphate binding | 4 | 18 |
GO:0036094 | small molecule binding | 2 | 18 |
GO:0043167 | ion binding | 2 | 18 |
GO:0043168 | anion binding | 3 | 18 |
GO:0045182 | translation regulator activity | 1 | 6 |
GO:0090079 | translation regulator activity, nucleic acid binding | 2 | 6 |
GO:0097159 | organic cyclic compound binding | 2 | 18 |
GO:0097367 | carbohydrate derivative binding | 2 | 18 |
GO:0140096 | catalytic activity, acting on a protein | 2 | 18 |
GO:1901265 | nucleoside phosphate binding | 3 | 18 |
GO:1901363 | heterocyclic compound binding | 2 | 18 |
GO:0004683 | calmodulin-dependent protein kinase activity | 5 | 5 |
GO:0016905 | myosin heavy chain kinase activity | 6 | 5 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 215 | 217 | PF00675 | 0.319 |
CLV_NRD_NRD_1 | 282 | 284 | PF00675 | 0.205 |
CLV_PCSK_KEX2_1 | 172 | 174 | PF00082 | 0.404 |
CLV_PCSK_KEX2_1 | 215 | 217 | PF00082 | 0.390 |
CLV_PCSK_KEX2_1 | 224 | 226 | PF00082 | 0.389 |
CLV_PCSK_PC1ET2_1 | 172 | 174 | PF00082 | 0.445 |
CLV_PCSK_PC1ET2_1 | 224 | 226 | PF00082 | 0.375 |
CLV_PCSK_SKI1_1 | 308 | 312 | PF00082 | 0.509 |
DEG_APCC_DBOX_1 | 158 | 166 | PF00400 | 0.230 |
DEG_SCF_FBW7_1 | 18 | 23 | PF00400 | 0.530 |
DOC_CYCLIN_RxL_1 | 343 | 354 | PF00134 | 0.365 |
DOC_CYCLIN_yCln2_LP_2 | 344 | 350 | PF00134 | 0.389 |
DOC_MAPK_gen_1 | 223 | 232 | PF00069 | 0.450 |
DOC_PP1_RVXF_1 | 83 | 89 | PF00149 | 0.392 |
DOC_USP7_MATH_1 | 12 | 16 | PF00917 | 0.573 |
DOC_WW_Pin1_4 | 14 | 19 | PF00397 | 0.561 |
DOC_WW_Pin1_4 | 20 | 25 | PF00397 | 0.780 |
DOC_WW_Pin1_4 | 33 | 38 | PF00397 | 0.617 |
DOC_WW_Pin1_4 | 331 | 336 | PF00397 | 0.533 |
LIG_14-3-3_CanoR_1 | 147 | 153 | PF00244 | 0.303 |
LIG_14-3-3_CanoR_1 | 159 | 169 | PF00244 | 0.306 |
LIG_14-3-3_CanoR_1 | 180 | 188 | PF00244 | 0.425 |
LIG_14-3-3_CanoR_1 | 215 | 220 | PF00244 | 0.234 |
LIG_14-3-3_CanoR_1 | 319 | 323 | PF00244 | 0.324 |
LIG_14-3-3_CanoR_1 | 77 | 86 | PF00244 | 0.459 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.489 |
LIG_BRCT_BRCA1_1 | 116 | 120 | PF00533 | 0.450 |
LIG_BRCT_BRCA1_1 | 173 | 177 | PF00533 | 0.220 |
LIG_Clathr_ClatBox_1 | 188 | 192 | PF01394 | 0.334 |
LIG_Clathr_ClatBox_1 | 229 | 233 | PF01394 | 0.492 |
LIG_FAT_LD_1 | 66 | 74 | PF03623 | 0.296 |
LIG_FHA_1 | 155 | 161 | PF00498 | 0.420 |
LIG_FHA_1 | 81 | 87 | PF00498 | 0.425 |
LIG_FHA_2 | 237 | 243 | PF00498 | 0.324 |
LIG_LIR_Apic_2 | 26 | 30 | PF02991 | 0.733 |
LIG_LIR_Gen_1 | 134 | 143 | PF02991 | 0.492 |
LIG_LIR_Gen_1 | 233 | 241 | PF02991 | 0.309 |
LIG_LIR_Gen_1 | 321 | 330 | PF02991 | 0.490 |
LIG_LIR_Nem_3 | 134 | 139 | PF02991 | 0.433 |
LIG_LIR_Nem_3 | 174 | 179 | PF02991 | 0.398 |
LIG_LIR_Nem_3 | 203 | 209 | PF02991 | 0.332 |
LIG_LIR_Nem_3 | 233 | 238 | PF02991 | 0.309 |
LIG_LIR_Nem_3 | 321 | 326 | PF02991 | 0.520 |
LIG_LIR_Nem_3 | 60 | 66 | PF02991 | 0.473 |
LIG_MLH1_MIPbox_1 | 116 | 120 | PF16413 | 0.392 |
LIG_MLH1_MIPbox_1 | 173 | 177 | PF16413 | 0.220 |
LIG_NRBOX | 362 | 368 | PF00104 | 0.404 |
LIG_Pex14_2 | 132 | 136 | PF04695 | 0.285 |
LIG_REV1ctd_RIR_1 | 174 | 184 | PF16727 | 0.308 |
LIG_SH2_CRK | 323 | 327 | PF00017 | 0.382 |
LIG_SH2_GRB2like | 119 | 122 | PF00017 | 0.401 |
LIG_SH2_GRB2like | 202 | 205 | PF00017 | 0.236 |
LIG_SH2_STAP1 | 202 | 206 | PF00017 | 0.259 |
LIG_SH2_STAP1 | 359 | 363 | PF00017 | 0.570 |
LIG_SH2_STAT5 | 119 | 122 | PF00017 | 0.295 |
LIG_SH2_STAT5 | 202 | 205 | PF00017 | 0.350 |
LIG_SH2_STAT5 | 54 | 57 | PF00017 | 0.372 |
LIG_SH3_3 | 136 | 142 | PF00018 | 0.380 |
LIG_SH3_3 | 332 | 338 | PF00018 | 0.567 |
LIG_SH3_3 | 44 | 50 | PF00018 | 0.443 |
LIG_SH3_3 | 69 | 75 | PF00018 | 0.323 |
LIG_SUMO_SIM_par_1 | 345 | 355 | PF11976 | 0.399 |
LIG_TRAF2_1 | 218 | 221 | PF00917 | 0.392 |
LIG_TRAF2_1 | 89 | 92 | PF00917 | 0.259 |
LIG_TYR_ITIM | 320 | 325 | PF00017 | 0.325 |
LIG_UBA3_1 | 299 | 305 | PF00899 | 0.339 |
LIG_UBA3_1 | 341 | 346 | PF00899 | 0.418 |
LIG_WRC_WIRS_1 | 149 | 154 | PF05994 | 0.284 |
MOD_CDK_SPK_2 | 20 | 25 | PF00069 | 0.774 |
MOD_CDK_SPxK_1 | 331 | 337 | PF00069 | 0.566 |
MOD_CK1_1 | 178 | 184 | PF00069 | 0.311 |
MOD_CK1_1 | 236 | 242 | PF00069 | 0.295 |
MOD_CK1_1 | 243 | 249 | PF00069 | 0.295 |
MOD_CK1_1 | 318 | 324 | PF00069 | 0.482 |
MOD_CK1_1 | 349 | 355 | PF00069 | 0.444 |
MOD_CK1_1 | 80 | 86 | PF00069 | 0.262 |
MOD_CK2_1 | 20 | 26 | PF00069 | 0.578 |
MOD_CK2_1 | 215 | 221 | PF00069 | 0.413 |
MOD_CK2_1 | 236 | 242 | PF00069 | 0.344 |
MOD_CK2_1 | 349 | 355 | PF00069 | 0.448 |
MOD_CK2_1 | 38 | 44 | PF00069 | 0.416 |
MOD_DYRK1A_RPxSP_1 | 331 | 335 | PF00069 | 0.416 |
MOD_GlcNHglycan | 173 | 176 | PF01048 | 0.254 |
MOD_GlcNHglycan | 183 | 186 | PF01048 | 0.306 |
MOD_GlcNHglycan | 242 | 245 | PF01048 | 0.344 |
MOD_GlcNHglycan | 363 | 366 | PF01048 | 0.448 |
MOD_GSK3_1 | 12 | 19 | PF00069 | 0.805 |
MOD_GSK3_1 | 171 | 178 | PF00069 | 0.430 |
MOD_GSK3_1 | 236 | 243 | PF00069 | 0.307 |
MOD_GSK3_1 | 342 | 349 | PF00069 | 0.401 |
MOD_GSK3_1 | 361 | 368 | PF00069 | 0.324 |
MOD_GSK3_1 | 93 | 100 | PF00069 | 0.469 |
MOD_N-GLC_1 | 109 | 114 | PF02516 | 0.381 |
MOD_N-GLC_1 | 197 | 202 | PF02516 | 0.401 |
MOD_N-GLC_1 | 308 | 313 | PF02516 | 0.417 |
MOD_N-GLC_1 | 315 | 320 | PF02516 | 0.340 |
MOD_NEK2_1 | 240 | 245 | PF00069 | 0.295 |
MOD_NEK2_1 | 3 | 8 | PF00069 | 0.604 |
MOD_NEK2_1 | 361 | 366 | PF00069 | 0.518 |
MOD_NEK2_1 | 93 | 98 | PF00069 | 0.433 |
MOD_PIKK_1 | 329 | 335 | PF00454 | 0.606 |
MOD_PIKK_1 | 77 | 83 | PF00454 | 0.361 |
MOD_PKA_1 | 215 | 221 | PF00069 | 0.259 |
MOD_PKA_2 | 179 | 185 | PF00069 | 0.425 |
MOD_PKA_2 | 215 | 221 | PF00069 | 0.259 |
MOD_PKA_2 | 318 | 324 | PF00069 | 0.493 |
MOD_PKA_2 | 361 | 367 | PF00069 | 0.464 |
MOD_Plk_1 | 315 | 321 | PF00069 | 0.343 |
MOD_Plk_4 | 148 | 154 | PF00069 | 0.392 |
MOD_Plk_4 | 243 | 249 | PF00069 | 0.308 |
MOD_Plk_4 | 318 | 324 | PF00069 | 0.355 |
MOD_Plk_4 | 346 | 352 | PF00069 | 0.605 |
MOD_Plk_4 | 65 | 71 | PF00069 | 0.459 |
MOD_ProDKin_1 | 14 | 20 | PF00069 | 0.565 |
MOD_ProDKin_1 | 25 | 31 | PF00069 | 0.700 |
MOD_ProDKin_1 | 33 | 39 | PF00069 | 0.611 |
MOD_ProDKin_1 | 331 | 337 | PF00069 | 0.534 |
MOD_SUMO_rev_2 | 267 | 272 | PF00179 | 0.362 |
TRG_DiLeu_BaEn_1 | 44 | 49 | PF01217 | 0.358 |
TRG_ENDOCYTIC_2 | 210 | 213 | PF00928 | 0.371 |
TRG_ENDOCYTIC_2 | 322 | 325 | PF00928 | 0.415 |
TRG_ER_diArg_1 | 225 | 228 | PF00400 | 0.360 |
TRG_NLS_MonoExtN_4 | 223 | 228 | PF00514 | 0.351 |
TRG_Pf-PMV_PEXEL_1 | 77 | 81 | PF00026 | 0.345 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I1L4 | Leptomonas seymouri | 54% | 100% |
A0A0S4IVQ7 | Bodo saltans | 30% | 85% |
A0A0S4J072 | Bodo saltans | 54% | 86% |
A0A1X0NJ27 | Trypanosomatidae | 47% | 100% |
A0A3Q8IGH4 | Leishmania donovani | 54% | 100% |
A0A3Q8IJS7 | Leishmania donovani | 100% | 100% |
A4HPX1 | Leishmania braziliensis | 80% | 97% |
A4HPX3 | Leishmania braziliensis | 57% | 99% |
A4IDN5 | Leishmania infantum | 54% | 100% |
C9ZME6 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 44% | 100% |
C9ZWN7 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 45% | 100% |
E9ATN7 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 91% | 100% |
E9ATN9 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 54% | 100% |
Q4Q0U3 | Leishmania major | 53% | 100% |
Q4Q0W0 | Leishmania major | 89% | 100% |
V5AN54 | Trypanosoma cruzi | 48% | 100% |